Refine your interests »
On March 27, 2023, the U.S. Supreme Court heard oral arguments in Amgen Inc. v. Sanofi, a closely watched case on the issue of enablement under 35 U.S.C. ยง 112(a). Though not the main point of contention, the doctrine of...more